Cannabis stocks & MSOS stock analysis & is the rally over or will MSOS stock surge again

GSK to acquire Chimagen’s CMG1A46 for autoimmune treatment

The acquisition of CMG1A46 is a strategic move to address the diverse manifestations of lupus and the ongoing burden it places on patients. Credit: Indypendenz/Shutterstock.

October 30, 2024

Unlocking secrets of aging: ENABL age offers detailed, individualized aging profiles using cutting-edge AI techniques

Combining machine learning with explainable artificial intelligence (XAI) to predict biological age with personalized explanations.

November 9, 2023

ActiveHip+ enhances recovery for elderly hip fracture patients

This digital solution was developed as part of a European project led by the University of Granada (UGR) and the Andalusian Health Service (SAS).

July 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.